Literature DB >> 34129161

Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Rafael Ochoa-Sanchez1, Farzaneh Tamnanloo1, Christopher F Rose2.   

Abstract

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome of both acute and chronic liver disease. As a metabolic disorder, HE is considered to be reversible and therefore is expected to resolve following the replacement of the diseased liver with a healthy liver. However, persisting neurological complications are observed in up to 47% of transplanted patients. Several retrospective studies have shown that patients with a history of HE, particularly overt-HE, had persistent neurological complications even after liver transplantation (LT). These enduring neurological conditions significantly affect patient's quality of life and continue to add to the economic burden of chronic liver disease on health care systems. This review discusses the journey of the brain through the progression of liver disease, entering the invasive surgical procedure of LT and the conditions associated with the post-transplant period. In particular, it will discuss the vulnerability of the HE brain to peri-operative factors and post-LT conditions which may explain non-resolved neurological impairment following LT. In addition, the review will provide evidence; (i) supporting overt-HE impacts on neurological complications post-LT; (ii) that overt-HE leads to permanent neuronal injury and (iii) the pathophysiological role of ammonia toxicity on astrocyte and neuronal injury/damage. Together, these findings will provide new insights on the underlying mechanisms leading to neurological complications post-LT.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ammonia toxicity; Astrocytes; Hepatic encephalopathy; Liver transplantation; Neurological complications; Neuronal cell loss

Mesh:

Year:  2021        PMID: 34129161     DOI: 10.1007/s11064-021-03372-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  130 in total

1.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Authors:  Hendrik Vilstrup; Piero Amodio; Jasmohan Bajaj; Juan Cordoba; Peter Ferenci; Kevin D Mullen; Karin Weissenborn; Philip Wong
Journal:  Hepatology       Date:  2014-07-08       Impact factor: 17.425

Review 2.  Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.

Authors:  Christopher F Rose; Piero Amodio; Jasmohan S Bajaj; Radha Krishan Dhiman; Sara Montagnese; Simon D Taylor-Robinson; Hendrik Vilstrup; Rajiv Jalan
Journal:  J Hepatol       Date:  2020-10-21       Impact factor: 25.083

3.  Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.

Authors:  Peter Jepsen; Peter Ott; Per Kragh Andersen; Henrik Toft Sørensen; Hendrik Vilstrup
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

4.  Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.

Authors:  P Amodio; F Del Piccolo; E Pettenò; D Mapelli; P Angeli; R Iemmolo; M Muraca; C Musto; G Gerunda; C Rizzo; C Merkel; A Gatta
Journal:  J Hepatol       Date:  2001-07       Impact factor: 25.083

5.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

6.  Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Puneeta Tandon; Florence Wong; Guadalupe Garcia-Tsao; Patrick S Kamath; Benedict Maliakkal; Scott W Biggins; Paul J Thuluvath; Michael B Fallon; Ram M Subramanian; Hugo E Vargas; Jennifer Lai; Leroy R Thacker; K Rajender Reddy
Journal:  Clin Gastroenterol Hepatol       Date:  2016-10-05       Impact factor: 11.382

7.  Patients with minimal hepatic encephalopathy have poor insight into their driving skills.

Authors:  Jasmohan S Bajaj; Kia Saeian; Muhammad Hafeezullah; Raymond G Hoffmann; Thomas A Hammeke
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10       Impact factor: 11.382

8.  Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients.

Authors:  Krystal T Sood; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2019-01-24

9.  Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy.

Authors:  Siamak M Seraj; Emily J Campbell; Sarah K Argyropoulos; Kara Wegermann; Raymond T Chung; James M Richter
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

Review 10.  Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.

Authors:  Sara Montagnese; Jasmohan S Bajaj
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

View more
  2 in total

Review 1.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

2.  Impact of Optimizing the Emergency Care Process on the Emergency Effect and Prognosis of Patients with Hepatic Encephalopathy.

Authors:  Fang Wei; Haihong Tan; Yubiao He; Xin Shu
Journal:  Emerg Med Int       Date:  2022-08-24       Impact factor: 1.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.